First-Steps With Time-Limited BTKi-B–cell lymphoma 2 Inhibitor Options in Treatment Naïve CLL - report from EHA2025

from Medical Digest & Congress Report · host Medical Congress News

Professor Lydia Scarfò shares her insights on BTKi-B–cell lymphoma 2 inhibitor options in treatment naïve CLL at the 2025 EHA Annual Meeting.Video: https://medicaldigest.org/scientific-contents/interview:first-steps-time-limited-btki-bcell-lymphoma-2-inhibitor-options-treatment-naive-cll

Episode metadata supplied by the publisher feed · Published Jun 23, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

First-Steps With Time-Limited BTKi-B–cell lymphoma 2 Inhibitor Options in Treatment Naïve CLL - report from EHA2025

0:00 6:49

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medical Digest & Congress Report?

This episode is 6 minutes long.

When was this Medical Digest & Congress Report episode published?

This episode was published on June 23, 2025.

Can I download this Medical Digest & Congress Report episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!